These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 8801376)
1. [Ecstasy, the drug of the route of bakalao]. Camí J; Farré M Med Clin (Barc); 1996 May; 106(18):711-6. PubMed ID: 8801376 [No Abstract] [Full Text] [Related]
2. [Effects of ecstasy on the body]. Saarijärvi S; Lopperi M Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183 [No Abstract] [Full Text] [Related]
3. Club drug use in Germany. Soellner R Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817 [TBL] [Abstract][Full Text] [Related]
4. [On ecstasy]. Boulu R Ann Pharm Fr; 2003 May; 61(3):155-6. PubMed ID: 12714927 [No Abstract] [Full Text] [Related]
5. Evidence for executive deficits among users of MDMA (Ecstasy). Fisk JE; Montgomery C; Murphy P; Wareing M Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532 [TBL] [Abstract][Full Text] [Related]
6. The lure of ecstasy. Cloud J Time; 2000 Jun; 155(23):62-8. PubMed ID: 10947376 [No Abstract] [Full Text] [Related]
8. [MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects]. Prada C; Alvarez FJ Med Clin (Barc); 1996 Oct; 107(14):549-55. PubMed ID: 8999216 [No Abstract] [Full Text] [Related]
9. [Drug abuse--explosion of Ecstasy in Oslo. Interview by Kari Anne Aase]. Banjeri T Tidsskr Sykepl; 1997 Mar; 85(5):24-5. PubMed ID: 9447156 [No Abstract] [Full Text] [Related]
10. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. Sumnall HR; Cole JC; Jerome L J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654 [TBL] [Abstract][Full Text] [Related]
11. What is a dose of ecstasy? Cole JC; Sumnall HR; Wagstaff GF J Psychopharmacol; 2002 Jun; 16(2):189-90. PubMed ID: 12095080 [No Abstract] [Full Text] [Related]
12. Ecstasy is making a comeback, European drugs report warns. Watson R BMJ; 2016 May; 353():i3078. PubMed ID: 27245254 [No Abstract] [Full Text] [Related]
13. Correlates of Ecstasy use in middle age and beyond. Williams P Drug Alcohol Rev; 2005 Jan; 24(1):33-8. PubMed ID: 16191719 [TBL] [Abstract][Full Text] [Related]
15. A brief overview of the clinical pharmacology of "club drugs". Britt GC; McCance-Katz EF Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813 [TBL] [Abstract][Full Text] [Related]
17. [Ecstasy: a review of scientific literature about MDMA]. Caudevilla Gálligo F Med Clin (Barc); 2003 Apr; 120(13):505-15. PubMed ID: 12716545 [No Abstract] [Full Text] [Related]
18. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users. Fisk JE; Montgomery C; Murphy PN Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632 [TBL] [Abstract][Full Text] [Related]
19. Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. Hopper JW; Su Z; Looby AR; Ryan ET; Penetar DM; Palmer CM; Lukas SE Drug Alcohol Depend; 2006 Dec; 85(3):221-35. PubMed ID: 16730923 [TBL] [Abstract][Full Text] [Related]
20. [Ecstasy, a new designer drug in the techno-scene]. Kuhlmann T Psychiatr Prax; 1996 Nov; 23(6):266-9. PubMed ID: 9036394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]